Cargando…
cGMP Imaging in Brain Slices Reveals Brain Region-Specific Activity of NO-Sensitive Guanylyl Cyclases (NO-GCs) and NO-GC Stimulators
Impaired NO-cGMP signaling has been linked to several neurological disorders. NO-sensitive guanylyl cyclase (NO-GC), of which two isoforms—NO-GC1 and NO-GC2—are known, represents a promising drug target to increase cGMP in the brain. Drug-like small molecules have been discovered that work synergist...
Autores principales: | Peters, Stefanie, Paolillo, Michael, Mergia, Evanthia, Koesling, Doris, Kennel, Lea, Schmidtko, Achim, Russwurm, Michael, Feil, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122017/ https://www.ncbi.nlm.nih.gov/pubmed/30087260 http://dx.doi.org/10.3390/ijms19082313 |
Ejemplares similares
-
Differential role of NO-sensitive guanylyl cyclase isoforms NO-GC1 and NO-GC2 in auditory function in adult mice
por: Möhrle, Dorit, et al.
Publicado: (2015) -
PDE2, a component of the NO/cGMP signalling in the hippocampus
por: Schönle, Isabel, et al.
Publicado: (2011) -
The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report
por: Friebe, Andreas, et al.
Publicado: (2023) -
NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015) -
Signaling via guanylyl cyclase C: cGMP, Src and p21
por: Basu, Nirmalya, et al.
Publicado: (2011)